Analysen von Michael Leuchten

11.02.21 AstraZeneca Neutral UBS AG
08.02.21 AstraZeneca Neutral UBS AG
03.02.21 Novo Nordisk Neutral UBS AG
26.01.21 AstraZeneca Neutral UBS AG
21.01.21 Merck Neutral UBS AG
14.01.21 AstraZeneca Neutral UBS AG
17.12.20 Novo Nordisk Neutral UBS AG
14.12.20 AstraZeneca Neutral UBS AG
09.12.20 AstraZeneca Neutral UBS AG
30.11.20 AstraZeneca Neutral UBS AG
17.11.20 Merck Neutral UBS AG
12.11.20 Merck Neutral UBS AG
09.11.20 Novo Nordisk Neutral UBS AG
02.11.20 Novo Nordisk Neutral UBS AG
30.10.20 Novo Nordisk Neutral UBS AG
09.10.20 Novo Nordisk Neutral UBS AG
25.09.20 Novo Nordisk Neutral UBS AG
18.08.20 Novo Nordisk Neutral UBS AG
07.08.20 Merck Neutral UBS AG
06.08.20 Novo Nordisk Neutral UBS AG
20.07.20 Novo Nordisk Neutral UBS AG
05.06.20 Novo Nordisk Neutral UBS AG
14.05.20 Novo Nordisk Neutral UBS AG
14.05.20 Merck Neutral UBS AG
11.05.20 Novo Nordisk Neutral UBS AG
22.04.20 Sartorius vz. Neutral UBS AG
10.03.20 Merck Neutral UBS AG
06.03.20 Merck Neutral UBS AG
06.02.20 Novo Nordisk Neutral UBS AG
17.01.20 Novo Nordisk Neutral UBS AG
09.12.19 Sartorius vz. Neutral UBS AG
06.12.19 Novo Nordisk Neutral UBS AG
26.11.19 Merck Neutral UBS AG
21.11.19 Novo Nordisk Neutral UBS AG
18.11.19 Novo Nordisk Neutral UBS AG
14.11.19 Merck Neutral UBS AG
21.10.19 Sartorius vz. Neutral UBS AG
08.08.19 Merck Neutral UBS AG
25.07.19 Roche Neutral UBS AG
19.07.19 Sartorius vz. Neutral UBS AG
02.07.19 Sartorius vz. Neutral UBS AG
14.05.19 Merck Neutral UBS AG
13.05.19 Merck Neutral UBS AG
25.04.19 Merck Neutral UBS AG
24.04.19 Novartis Neutral UBS AG
18.04.19 Sartorius vz. Neutral UBS AG
17.04.19 Roche Neutral UBS AG
09.04.19 Merck Neutral UBS AG
01.04.19 AstraZeneca Neutral UBS AG
01.04.19 Merck Neutral UBS AG